Schwartsmann, Gilberto

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet

Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology

Cited by 1,222

Marine organisms as a source of new anticancer agents

Schwartsmann, G., da Rocha, A. B., Berlinck, R. G., & Jimeno, J. (2001) · The Lancet Oncology

Marine Sponges and Natural ProductsMicrobial Natural Products and Biosynthesis

Cited by 261

Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds

Mans, D. R. A., Rocha, A. B., & Schwartsmann, G. (2000) · The Oncologist

Phytochemistry Medicinal Plant ApplicationsEthnobotanical and Medicinal Plants Studies

Cited by 254

Marine organisms and other novel natural sources of new cancer drugs

Schwartsmann, G. (2000) · Annals of Oncology

Marine Sponges and Natural ProductsMicrobial Natural Products and Biosynthesis

Cited by 81